Company: ECIA
Filing Date: 2025-08-15
Form Type: NT 10-Q
Source: 0001079973-25-001324
Chunk: 1

Company: ENCISION INC
Filing Date: 2025-08-15
Form: NT 10-Q
Chunk 1
---
10-D,   
 or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and                              |                                                                          |
|   | -c |    | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.                                   |                                                                          |

<div align='center'>PART III — NARRATIVE</div>

State below in reasonable detail the reasons why Forms 10-K, 20-F,
11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Encision Inc. was unable to timely file its Form 10-Q for the quarter
ended June 30, 2025 due to unexpected complications with the inline XBRL process on the filing due date. Encison Inc. expects to file
its Form 10-Q within the five-day extension period provided by Rule 12b-25

<div align='center'>PART IV — OTHER INFORMATION</div>

| (1) | Name and telephone number of person to contact in regard to this notification. |

| Brandon Shepard |     |        303 |     | 444-2600          |
| (Name)          |     | -Area Code |     | -Telephone Number |

| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No |

| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?  ☐ Yes ☒ No |

| If so, attach an explanation of the anticipated change, both narratively                                            
 and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. |

<div align='center'>Encision Inc.

(Name of Registrant as Specified in Charter)</div>

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

| Date: |     | August 14, 2025 |     |        |     |                                          |
|